[This corrects the article on p. 3792 in vol. 7.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996191 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Correction: Communication and visiting policies in Italian intensive care units during the frst COVID-19 pandemic wave and lockdown: a nationwide survey.
BMC Anesthesiol
September 2022
Department of Anesthesia and Intensive Care, ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.
Correction to: COVID-19 pandemic preparation: using simulation for systems-based learning to prepare the largest healthcare workforce and system in Canada.
Adv Simul (Lond)
April 2021
eSIM Provincial Simulation Program, Alberta Health Services, Alberta Health Services, 1403 29th Street NW, Calgary, Alberta T2N 2 T9 Canada.
[This corrects the article DOI: 10.1186/s41077-020-00138-w.].
View Article and Find Full Text PDFA three year study on 14 VOCs at one site in Rome: levels, seasonal variations, indoor/outdoor ratio and temporal trends.
Int J Environ Res Public Health
October 2010
Igiene degli Ambienti di Vita, Dipartimento Ambiente e Connessa Prevenzione Primaria, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italia. [corrected]
Fourteen volatile organic compounds (VOCs)-twelve hydrocarbons and two organochlorine compounds-were monitored both outdoors and indoors for three years at one site in Rome. Results showed that 118 out of 168 indoor seasonal mean values were higher than the corresponding outdoor concentrations. The most relevant source of outdoor hydrocarbons was automotive exhaust emissions.
View Article and Find Full Text PDFCorrection: Fuselli, et al. A Three Year Study on 14 VOCs at One Site in Rome: Levels, Seasonal Variations, Indoor / Outdoor Ratio and Temporal Trends. Int. J. Environ. Res. Public Health 2010, 7, 3792-3803.
Int J Environ Res Public Health
October 2010
Igiene degli Ambienti di Vita, Dipartimento Ambiente e Connessa Prevenzione Primaria, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italia; E-Mails: (S.F.); (M.D.F.); (R.M.).
[This corrects the article on p. 3792 in vol. 7.
View Article and Find Full Text PDFBackground: Ivabradine specifically inhibits the I(f) current in the sinoatrial node to lower heart rate, without affecting other aspects of cardiac function. We aimed to test whether lowering the heart rate with ivabradine reduces cardiovascular death and morbidity in patients with coronary artery disease and left-ventricular systolic dysfunction.
Methods: Between December, 2004, and December, 2006, we screened 12 473 patients at 781 centres in 33 countries.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!